Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-20-007279
Filing Date
2020-04-28
Accepted
2020-04-28 17:00:17
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm 10-K/A 430299
2 ex31-3.htm EX-31.3 6307
3 ex31-4.htm EX-31.4 6224
  Complete submission text file 0001493152-20-007279.txt   443959
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

EIN.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12830 | Film No.: 20825905
SIC: 2836 Biological Products, (No Diagnostic Substances)